|4Aug 23, 4:28 PM ET

Chudnovsky Yekaterina 4

4 · Immix Biopharma, Inc. · Filed Aug 23, 2023

Insider Transaction Report

Form 4
Period: 2023-08-22
Chudnovsky Yekaterina
Director10% Owner
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-08-22+20,00020,000 total
    Exercise: $1.80Exp: 2033-08-22Common Stock (20,000 underlying)
  • Award

    Stock Option (Right to Buy)

    2023-08-22+16,67016,670 total
    Exercise: $1.80Exp: 2033-08-22Common Stock (16,670 underlying)
Footnotes (2)
  • [F1]The Stock Option will vest in thirty-six (36) equal monthly installments following the date of grant, subject to the Reporting Person's continued service on the Board of Directors.
  • [F2]The Stock Option will vest in ten (10) equal monthly installments following the date of grant and any remaining unvested shares will become fully vested and exercisable on the date of the 2024 annual shareholder meeting, subject to the Reporting Person's continued service on the Board of Directors.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION